What: As of April 1, 2014, Medicis Canada (a division of Valeant Canada) has officially launched Dysport for use in aesthetic medicine in Canada. One of Europe’s leading cosmetic injectables, Dysport is indicated for temporary improvement in the appearance of moderate to severe glabellar lines in adult patients.
About: Dysport is administered by intramuscular injection and temporarily reduces movement of certain upper facial muscles that cause wrinkles.The active substance is a botulinum neurotoxin type A complex which acts at the level of the neuromuscular junction in the targeted muscle to block acetylcholine secretion, thereby reducing muscular spasm.
Initially developed to treat motor disorders and various forms of muscular spasticity, including cervical dystonia, Dysport was later developed for the treatment of a wide variety of neuromuscular disorders, as well as for use in aesthetic medicine.
Bonus: It’s the only botulinum toxin, a compound derived from a bacterium, that inhibits the transmission of nerve impulses to the muscle with an onset as early as 24 hours for some patients.
Results last up to four months, providing a soft, smooth and natural look. FDA approved, there is “no downtime” after the treatment – patients can quickly return back to their normal activities with little or no side effects. Can be utilized by younger adult patients as a preventative measure to offset the early signs of ageing.
**Save $50 for a limited time when you receive a Dysport treatment. Redeem your $50 rebate between February 15 – May 15, 2014.**
For more info or to find a participating doctor near you visit www.dysportcanada.ca.